Phebra Acquires Equity Stake In Uk Specialty Hospital Pharma Company Flexipharm Austrading
Acquiring Company
Phebra
Acquired Company
Flexipharm Austrading
Description
Leading Australian pharmaceutical group Phebra Holdings ('Phebra') is pleased to announce that it has completed a share purchase agreement with the UK hospital specialty pharmaceutical company Flexipharm Austrading Limited ('FAL').
Quick answer
Phebra is acquiring Flexipharm Austrading, announced November 3, 2021.
- How much did Phebra pay for Flexipharm Austrading?
- The deal value was not disclosed.
- What does Phebra do?
- Phebra is an Australian based specialty pharmaceutical group which develops, manufactures and markets critical medicines across the world.
Source: Fundz verified event record.
Other recent acquisitions in Science And Engineering and Consumer Goods
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Redwire Acquires Techshot, The Leader In Space Biotechnology (November 2, 2021)
- Symphony Retailai Acquires Shelf Intelligence Saas Technology Leader Retech Labs (October 27, 2021)
- Procore Acquires Laborchart To Improve Construction Workforce Management (October 22, 2021)
- Questionpro Acquires Bryght Ai (November 1, 2021)
- Voicesage Acquires 2Sms To Strengthen Its Presence In The U.S. Market (October 29, 2021)
- Ilumivu Announces Acquisition Of Cardiogram And Series A Investment Round To Accelerate Personalized Decision Support Solutions For Healthcare (October 21, 2021)
Who to call at Phebra, and when
When Phebra changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Phebra raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Phebra, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Phebra. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Phebra makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Flexipharm Austrading?
Flexipharm Austrading was acquired by Phebra. The deal was reported on November 3, 2021. Phebra is an Australian based specialty pharmaceutical group which develops, manufactures and markets critical medicines across the world. Phebra is privately held and operates in Biotechnology.
When did Phebra acquire Flexipharm Austrading?
Phebra's acquisition of Flexipharm Austrading was reported on November 3, 2021. Leading Australian pharmaceutical group Phebra Holdings ('Phebra') is pleased to announce that it has completed a share purchase agreement with the UK hospital specialty pharmaceutical company Flexipharm Austrading Limited ('FAL'). Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Flexipharm Austrading do?
Flexipharm Austrading's vision is to become a UK-based specialty pharmaceutical company that is genuinely respected and trusted by NHS hospitals. It is privately held, operating in Software.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.